Effects of stevia on glycemic and lipid profile of type 2 diabetic patients: A randomized controlled trial | ||
| Avicenna Journal of Phytomedicine | ||
| مقاله 3، دوره 10، شماره 2، خرداد و تیر 2020، صفحه 118-127 اصل مقاله (447.17 K) | ||
| نوع مقاله: Short communication | ||
| شناسه دیجیتال (DOI): 10.22038/ajp.2019.13652 | ||
| نویسندگان | ||
| Marjan Ajami1؛ Maryam Seyfi2؛ Fatemeh Abdollah Pouri Hosseini2؛ Parisa Naseri3؛ Aynaz Velayati2؛ Fahimeh Mahmoudnia4؛ Maliheh Zahedirad5؛ Majid Hajifaraji* 1 | ||
| 1Department of Food and Nutrition Policy and Planning Research, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran. | ||
| 2Nutritional Sciences, National Nutrition and Food Technology Research Institute, School of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran. | ||
| 3Department of Biostatistics, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences. Tehran. Iran. | ||
| 4Department of Biology, Faculty of Science, Farhangian University, Tehran, Iran | ||
| 5Department of Nutrition, School of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran. | ||
| چکیده | ||
| Objective: Stevia (Stevia rebaudiana Bertoni) is a natural and healthyalternative sweetener to sugar and artificial sweeteners, which has become important for human diets and food manufactures. In this study, the effects of stevia or sucralose as tea sweeteners on glycemic and lipid profile of type 2 diabetic patients were investigated. Materials and Methods: A double-blind clinical trial was carried out in 34 type 2 diabetic patients. These patients were assigned into two groups of stevia (n=15) (received 1 cup of 2% stevia extract-sweet tea in three meals) and non-stevia (n=19) (received one tablet of sucralose sweetener) daily for eight weeks. Glycemic response and lipid profile of the participants were assessed. Furthermore, height, weight and body mass index (BMI) of the participants were measured as well as their dietary intakes at the baseline and at the end of the study. Results: Findings showed no significant differences in fasting blood sugar (FBS) levels between the base line and after two hours, in participants. Also, no significant differences in insulin, glycosylated hemoglobin (HbA1C) and lipid levels were found between the two groups. Conclusion: Results of the current study showed that the highlighted doses of stevia in sweetened tea could be an alternative to sucralose in diabetic patients with no effects on blood glucose, HbA1C, insulin and lipid levels. | ||
| کلیدواژهها | ||
| Stevia؛ Sucralose؛ Type 2 diabetes؛ Glycemic response؛ Lipid profile | ||
| مراجع | ||
|
Abo Elnaga NIE, Massoud MI, Yousef MI, Mohamed HHA. 2016. Effect of stevia sweetener consumption as non-caloric sweetening on body weight gain and biochemical’s parameters in overweight female rats. Ann Agr Sci, 61: 155–163.
Anton SD,Martin CK, Han H, Coulon S, Cefalu WT, Geiselman P, Williamson DA. 2010. Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels. Appetite, 55: 37–43.
Awney HA, Massoud MI, El-Maghrabi S. 2011. Long-term feeding effects of stevioside sweetener on some toxicological parameters of growing male rats. J Appl Toxicol, 31: 431–438.
Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SMJ, Khodaee G, Hosseini J, Abasalti Z, Hassankhani B, Ferns G. 2008. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 49: 571–576.
Brown RJ, De Banate MA, Rother KI. 2010. Artificial Sweeteners: A systematic review of metabolic effects in youth. Int J Pediatr Obes, 5: 305–312.
Chavushyan VA, Simonyan KV, Simonyan RM, Isoyan AS, Simonyan RA, Babakhanyan MA, Hovhannisyian LE, Nahapetyan KhH, Avetisyan LG, Simonyan MA. 2017. Effects of stevia on synaptic plasticity and NADPH oxidase level of CNS in conditions of metabolic disorders caused by fructose. BMC Complement Altern Med, 17: 540-552.
Gardner C, Wylie-Rosett J, Gidding SS, Steffen LM, Johnson RK, Reader D, Lichtenstein AH. 2012. Nonnutritive sweeteners: current use and health perspectives: a scientific statement from the American heart association and the American diabetes association. Diabetes Care, 35: 1798–1808.
Geeraert B, Crombe F, Hulsmans M, Benhabiles N, Geuns JM, Holvoet P. 2010. Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice. Int J Obes (Lond), 34: 569–577.
Geuns JM, Buyse J, Vankeirsbilck A, Temme EH. 2007. Metabolism of stevioside by healthy subjects. Exp Biol Med (Maywood), 232: 164–173.
Goyal SK, Samsher, Goyal RK. 2010. Stevia (Stevia rebaudiana) a bio-sweetener: a review. Int J Food Sci Nutr, 61: 1–10.
Gregersen S, Jeppesen PB, Holst JJ, Hermansen K. 2004. Antihyperglycemic effects of stevioside in type 2 diabetic subjects. Metabolism, 53:73-76.
Karimi M, Ahmadi A, Hashemi J, Abbasi A, Angelini LG. 2014. Effect of two plant growth retardants on steviol glycosides content and antioxidant capacity in Stevia (Stevia rebaudiana Bertoni). Acta Physiol Plant. 36: 1211–1219.
Lemus-Mondaca R, Vega-Galvez A, Zura-Bravo L, Ah-Hen K. 2012. Stevia rebaudiana Bertoni, source of a high-potency natural sweetener: A comprehensive review on the biochemical, nutritional and functional aspects. Food Chem, 132: 1121–1132.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K,Aboyans V, Adair T, Aggarwal R, YAhn S, AAlMazroa M, Alvarado M, Anderson HR, Anderson LM,Atkinson KGC, Baddour LM, Barker-Collo S,Murray CJL.2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study. Lancet, 380: 2095–2128.
Misra H, Soni M, Silawat N,Mehta D, Mehta BK, and Jain DC. 2011. Antidiabetic activity of medium-polar extract from the leaves of Stevia rebaudiana Bert. (Bertoni) on alloxan-induced diabetic rats. J Pharm Bioall Sci, 3: 242–248.
Momtazi-Borojeni AA, Esmaeili SA, Abdollahi E, Sahebkar A. 2017. A review on the pharmacology and toxicology of steviol glycosides extracted from stevia rebaudiana. Curr Pharm Des, 23: 1616–1622.
Philippaert K, Pironet A, Mesuere M, Sones W, Vermeiren L, Kerselaers S, Pinto S, Segal A, Antoine N, Gysemans C, Laureys J, Lemaire K, Gilon P, Cuypers E, Tytgat J, Mathieu C, Frans S, Rorsman P, Talavera K, Voets T, Vennekens R. 2017. Steviol glycosides enhance pancreatic beta-cell function and taste sensation by potentiation of TRPM5 channel activity. Nat Commun, 8: 14733-14748.
Potocnjak I, Broznic D, Kindl M, Kropek M, Vladimir-Knezevic S, Domitrovic R. 2017. Stevia and stevioside protect against cisplatin nephrotoxicity through inhibition of ERK1/2, STAT3, and NF-kappaB activation. Food Chem Toxicol, 107: 215–225.
Prakash I, Ma G, Bunders C, Charan R.D, Ramirez C, Devkota K.P, Snyder T.M. 2017. A Novel Diterpene glycoside with nine glucose units from stevia rebaudiana bertoni. Biomolecules, 7: 10-20.
Reid AE, Chauhan BF, Rabbani R, Lys J, Copstein L, Mann A, Abou-Setta AM, Fiander M, MacKay DS, McGavock J, Wicklow B, Zarychanski R, Azad MB. 2016. Early exposure to nonnutritive sweeteners and long-term metabolic health: a systematic review. Pediatrics, 137: e20153603.
Romo-Romo A, Aguilar-Salinas CA, Brito-Cordova GX, Gomez Diaz RA, Vilchis Valentin D, Almeda-Valdes P. 2016. Effects of the non-nutritive sweeteners on glucose metabolism and appetite regulating hormones: systematic review of observational prospective studies and clinical trials. PLoS One, 11: e0161264.
Ruiz JCR, Ordoñez YBM, Basto AM, y Campos MRS. 2014. Antioxidant capacity of leaf extracts from two Stevia rebaudiana Bertoni varieties adapted to cultivation in Mexico. Nutr Hosp, 31: 1163–1170.
Sharma S, Walia S, Singh B, Kumar R. 2016. Comprehensive review on agro technologies of low-calorie natural sweetener stevia (Stevia rebaudiana Bertoni): a boon to diabetic patients. J Sci Food Agric, 96: 1867–1879.
Swithers SE. 2013. Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. Trends Endocrinol Metab, 24: 431–441.
Talevi A. 2017. Beneficial effects of stevia rebaudiana bertoni and steviol-related compounds on health, in sweeteners: pharmacology, biotechnology, and applications. Springer International Publishing: Cham. pp.1–22.
Tandel, KR, 2011. Sugar substitutes: Health controversy over perceived benefits. J Pharmacol Pharmacother, 2: 236–243.
World Health Organization. 2006. Safety evaluation of certain contaminants in food. Prepared by the Sixty-fourth meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). FAO Food Nutr Pap, 82: 1–778.
Xu, D, Du W, Zhao L, Davey A.K, Wang J. 2008. The neuroprotective effects of isosteviol against focal cerebral ischemia injury induced by middle cerebral artery occlusion in rats. Planta Med, 74: 816–821.
Xu D, Li Y, Wang J, Davey AK, Zhang S, Evans AM. 2007. The cardioprotective effect of isosteviol on rats with heart ischemia-reperfusion injury. Life Sci, 80: 269–274.
Yadav AK, Singh S, Dhyani D, Ahuja PS. 2011. A review on the improvement of stevia [Stevia rebaudiana (Bertoni)]. Can J Plant Sci, 91: 1–27. | ||
|
آمار تعداد مشاهده مقاله: 19,825 تعداد دریافت فایل اصل مقاله: 3,308 |
||